PD-L1 expression of 742 newly diagnosed advanced respiratory and digestive system tumours in China based on SP142 assay.

被引：0
|
作者：
Chen, Yanhui
Wang, Yating
Yang, Bohang
Hu, Ying
Zeng, Hui
Zhang, Henghui
机构：
[1] Capital Med Univ, Beijing Ditan Hosp, Inst Infect Dis, Lab Emerging Infect Dis, Beijing, Peoples R China
[2] Genecast Precis Med Technol Inst, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Key Lab Emerging Infect Dis, Inst Infect Dis, Beijing Ditan Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e24298
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e24298
引用
收藏
页数：2
相关论文
共 50 条
  • [41] PD-L1 testing based on SP142 antibody in metastatic triple-negative breast cancer: summary of an expert round-table discussion
    Peg, Vicente
    Lopez-Garcia, Maria Angeles
    Comerma, Laura
    Peiro, Gloria
    Garcia-Caballero, Tomas
    Lopez, Angel Concha
    Suarez-Gauthier, Ana
    Ruiz, Irune
    Rojo, Federico
    FUTURE ONCOLOGY, 2021, 17 (10) : 1209 - 1218
  • [42] Discordance in PD-L1 expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancer
    Miyakoshi, Jun
    Yazaki, Shu
    Shimoi, Tatsunori
    Onishi, Mai
    Saito, Ayumi
    Kita, Shosuke
    Yamamoto, Kasumi
    Kojima, Yuki
    Sumiyoshi-Okuma, Hitomi
    Nishikawa, Tadaaki
    Sudo, Kazuki
    Noguchi, Emi
    Murata, Takeshi
    Shiino, Sho
    Takayama, Shin
    Suto, Akihiko
    Fujiwara, Yasuhiro
    Yoshida, Masayuki
    Yonemori, Kan
    VIRCHOWS ARCHIV, 2023, 483 (06) : 855 - 863
  • [43] Discordance in PD-L1 expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancer
    Jun Miyakoshi
    Shu Yazaki
    Tatsunori Shimoi
    Mai Onishi
    Ayumi Saito
    Shosuke Kita
    Kasumi Yamamoto
    Yuki Kojima
    Hitomi Sumiyoshi-Okuma
    Tadaaki Nishikawa
    Kazuki Sudo
    Emi Noguchi
    Takeshi Murata
    Sho Shiino
    Shin Takayama
    Akihiko Suto
    Yasuhiro Fujiwara
    Masayuki Yoshida
    Kan Yonemori
    Virchows Archiv, 2023, 483 : 855 - 863
  • [44] Comparison of PD-L1 tumor cell expression with 22C3, 28-8, and SP142 IHC assays across multiple tumor types
    Maule, Jake G.
    Clinton, Lani K.
    Graf, Ryon P.
    Xiao, Jinpeng
    Oxnard, Geoffrey R.
    Ross, Jeffrey S.
    Huang, Richard S. P.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (10)
  • [45] Assessment of Concordance between 22C3 and SP142 Immunohistochemistry Assays regarding PD-L1 Expression in Non-Small Cell Lung Cancer
    Haipeng Xu
    Gen Lin
    Cheng Huang
    Weifeng Zhu
    Qian Miao
    Xirong Fan
    Biao Wu
    Xiaobing Zheng
    Xiandong Lin
    Kan Jiang
    Dan Hu
    Chao Li
    Scientific Reports, 7
  • [46] Assessment of Concordance between 22C3 and SP142 Immunohistochemistry Assays regarding PD-L1 Expression in Non-Small Cell Lung Cancer
    Xu, Haipeng
    Lin, Gen
    Huang, Cheng
    Zhu, Weifeng
    Miao, Qian
    Fan, Xirong
    Wu, Biao
    Zheng, Xiaobing
    Lin, Xiandong
    Jiang, Kan
    Hu, Dan
    Li, Chao
    SCIENTIFIC REPORTS, 2017, 7
  • [47] PD-L1 expression evaluated by 22C3 antibody is a better prognostic marker than SP142/SP263 antibodies in breast cancer patients after resection
    Yoon Jin Cha
    Dooreh Kim
    Soong June Bae
    Sung Gwe Ahn
    Joon Jeong
    Hye Sun Lee
    Soyoung Jeon
    Tae-Kyung Yoo
    Woo-Chan Park
    Chang Ik Yoon
    Scientific Reports, 11
  • [48] PD-L1 expression evaluated by 22C3 antibody is a better prognostic marker than SP142/SP263 antibodies in breast cancer patients after resection
    Cha, Yoon Jin
    Kim, Dooreh
    Bae, Soong June
    Ahn, Sung Gwe
    Jeong, Joon
    Lee, Hye Sun
    Jeon, Soyoung
    Yoo, Tae-Kyung
    Park, Woo-Chan
    Yoon, Chang Ik
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [49] Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes
    Krawczyk, Pawel
    Jarosz, Bozena
    Kucharczyk, Tomasz
    Grenda, Anna
    Reszka, Katarzyna
    Pankowski, Juliusz
    Wojas-Krawczyk, Kamila
    Nicos, Marcin
    Szumilo, Justyna
    Trojanowski, Tomasz
    Milanowski, Janusz
    ONCOTARGET, 2017, 8 (38) : 64283 - 64293
  • [50] PD-L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B-cell lymphoma treated with rituximab-based multi-agent chemotherapy
    Suzuki, Yuka
    Kohno, Kei
    Matsue, Kosei
    Sakakibara, Ayako
    Ishikawa, Eri
    Shimada, Satoko
    Shimada, Kazuyuki
    Mabuchi, Seiyo
    Takahara, Taishi
    Kato, Seiichi
    Nakamura, Shigeo
    Satou, Akira
    CANCER MEDICINE, 2020, 9 (13): : 4768 - 4776
12345